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Background: All the relevant risk factors contributing to breast cancer etiology are not fully known. Exposure to
organochlorine pesticides has been linked to an increased incidence of the disease, although not all data have
been consistent. Most published studies evaluated the exposure to organochlorines individually, ignoring the
potential effects exerted by the mixtures of chemicals.
Methods: This population-based study was designed to evaluate the profile of mixtures of organochlorines
detected in 103 healthy women and 121 women diagnosed with breast cancer from Gran Canaria Island, and the
relation between the exposure to these compounds and breast cancer risk.
Results: The most prevalent mixture of organochlorines among healthy women was the combination of lindane
and endrin, and this mixture was not detected in any affected women. Breast cancer patients presented more
frequently a combination of aldrin, dichlorodiphenyldichloroethylene (DDE) and dichlorodiphenyldichloroethane
(DDD), and this mixture was not found in any healthy woman. After adjusting for covariables, the risk of breast
cancer was moderately associated with DDD (OR = 1.008, confidence interval 95% 1.001-1.015, p= 0.024).
Conclusions: This study indicates that healthy women show a very different profile of organochlorine pesticide
mixtures than breast cancer patients, suggesting that organochlorine pesticide mixtures could play a relevant role
in breast cancer risk.
Keywords: Breast cancer risk, Organochlorine pesticides mixtures, Dichlorodiphenyldichloroethane (DDD)Background
Breast cancer (BC) is the most common cancer diag-
nosed in women worldwide [1]. In Spain, BC is currently
the most significant cause of death from malignancies in
women [2]. Whereas BC mortality and incidence are
lower in mainland Spain than in other European coun-
tries, there are alarming rates of mortality because of
this type of cancer in the archipelago of the Canary* Correspondence: ldominguez@dcc.ulpgc.es
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reproduction in any medium, provided the orIslands, specifically in Gran Canaria Island (Figure 1)
[3,4].
The etiology of BC is complex, with genetic, epigenetic
and environmental factors contributing to the develop-
ment of the disease. BC risk is significantly influenced
by genetics, but over 70% of the women that are diag-
nosed have sporadic cancer or tumours not associated
with inheritance of any major identified high risk genes.
It is thought that the risk of BC can be modified by life-
style and environment. Besides the genetic influence, the
most established factors contributing to BC are related
to cumulative exposure of the breast tissue to endogen-
ous estrogens [5]. Thus, early menarche, late age at first
pregnancy, nulliparity, lactation, years of reproductivetd This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Geographic distribution of mortality for breast cancer among women in Spain during the period between the years 1996 to
2000. Numbers are referred to deaths per 100.000 inhabitants. (http://www.isciii.es/htdocs/centros/epidemiologia/libros/cancermsc.pdf).
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therapy have been associated to an estrogenic environ-
ment and implicated as BC risk factors. Because all the
relevant risk factors contributing to breast cancer eti-
ology are not fully known, other environmental factors
have been studied during the past decade, including
smoking habits [6], alcohol intake [7], obesity, diet [8,9],
and exposure to environmental contaminants [10,11].
Specifically, exposure to organohalogenated contami-
nants has been linked to BC etiology. Among environ-
mental contaminants linked to BC, most studies have
focused in organochlorine pesticides (OCPs) due to their
endocrine-disrupting properties (estrogenic or antian-
drogenic effects) observed both in in vivo and in vitro
studies [12,13], and to their biochemical characteristics
(high lipophilic and resistant to biotransformation) that
result in their accumulation in body fat. In fact, their
persistence in the environment leads to bioaccumulation
in animals and also to biomagnification in the food chain
[14], resulting in the bioaccumulation of these chemicals
in the human body, including adipose tissue, fatty tissue,
breast milk, or serum [15-18]. Their long half-lives in
human tissues make them a problem for up to several
decades [19-21]. Due to such circumstances, OCPs were
banned in the 1970s in most Western countries [22,23].
A number of OCPs such as dichlorodiphenyltrichlor-
oethane (DDT), aldrin or dieldrin, as well as itsmetabolites, are considered as xenoestrogens [16,24] and
have been linked to environment-induced breast cancer
[16,18,20]. Because dichlorodiphenyldichloroethylene
(DDE, the major metabolite of DDT) is the most preva-
lent organochlorine residue found in human tissues
[16,18,25], most studies have focused in the potential
role played by DDE as a risk factor for BC. However,
epidemiologic studies linking organochlorine pesticides
(mainly DDT-derivative pesticides) to BC risk have been
controversial. Although several earlier studies suggested
a positive association [20,26-29], other studies showed
no increased risk [30-32]. In any case, it has to be high-
lighted that most studies focused in the study of only
one compound, and they did not take into account that
human beings are exposed simultaneously to multiple
OCPs, and that the biological effects exerted by the mix-
ture of OCPs vary considerably from those exerted by
any OCP individually [33,34].
The level of contamination by OCPs showed by the
general population of the Canary Islands has been ex-
tensively studied. Despite the fact that most OCPs
pesticides were banned in Spain in the late 1970’s,
our results have already shown that the people living
in the Canary Islands presented a relatively high de-
gree of contamination by OCPs (including DDT and
its derivatives, aldrin dieldrin, endrin, and lindane).
Furthermore, such results seemed to indicate the
Table 1 Characteristics of the study population
Healthy women (n = 103) Patients (n = 121) P
Age (years)
Mean± SD
45.3 ± 13.8 58.0 ± 11.7 <0.001
< 35 31 (30.1%) 2 (1.7%) <0.001
35-44.9 23 (22.3%) 14 (11.6%)
45-54.9 23 (22.3%) 35 (28.9%)
55-64.9 17 (16.6%) 34 (28.1%)
>65 9 (8.7%) 36 (29.7%)
BMI (kg/m2)
Mean± SD
26.3 ± 4.3 27.7 ± 4.8 0.031
Lactation
≤ 8 months 64 (84.2%) 63 (76.8%) n. s.
>9 months 12 (15.8%) 19 (23.2%)
Smoking
Non-smokers 70 (70.7%) 95 (79.8%) n. s.
Smokers/
Ex-smoker
29 (29.3%) 24 (20.2%)
Menopause
Yes 6 (5.8%) 22 (18.2%) 0.024
No 77 (74.8%) 98 (81%)
ND 20 (19.4) 1 (0.8%)
Abbreviations: BMI, body mass index; SD, standard deviation; ND, not
determined;
n. s., non-significant.
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in the late 1990’s [23,35].
Bearing in mind the alarming rates of mortality by BC
among women from the Canary Islands (Spain) and
more specifically in women from Gran Canaria Island
[2,4], the aim of our study was to compare the profile of
mixtures of OCPs detected in women diagnosed with
BC living in Gran Canaria Island with that detected in
healthy women selected among participants from our
previous population-based studies, and secondarily to
evaluate whether OCPs´ exposure could be considered
as a risk factor for BC in such population.
Methods
Study group
Adult healthy women from Gran Canaria Island
(n = 103) were selected among the representative popula-
tion-sample obtained in the Canary Islands Nutrition
Survey (ENCA 1998) previously evaluated regarding
their OCPs serum levels. The characteristics and meth-
odology of this Nutritional Survey and all the data about
the level of contamination by OCPs showed by the
population of this Archipelago have been previously
published [23,35,36].
On the other hand, women with a histological con-
firmed first diagnosis of breast cancer (n = 121) were
recruited between April 1999 and June 2001 from the
two University Hospitals of Gran Canaria Island [37].
Cases and controls were selected according to place of
residence (Gran Canaria Island). The characteristics of
the studied population are shown in Table 1. The local
ethics committee approved the design of this study, and
informed consent was obtained from all the participants.
Sample collection
Approximately 40 ml of blood was collected from
each individual by venipuncture in a vacuum system
tube, refrigerated, and centrifuged at 4°C (15 min x
3,000 rpm) within 4 hours to obtain serum. Serum
was distributed in aliquots of 2–3 ml and immediately
frozen at −80°C. The serum aliquots were used to de-
termine biochemical (including lipid profile) and nu-
tritional parameters. Once these initial analyses were
completed, the remaining serum was kept frozen for
further chemical analyses. All collection and handling
equipment in contact with serum specimens were
tested for possible OCP contamination. No contamin-
ating material was identified.
Analytical methods
The OCPs residues measured in serum were: DDT isomers
1,1,1-trichloro-2,2-bis(p-chlorophenyl)ethane (p,p´-DDT),
1,1,1-trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)eth-




(o,p´-DDD); the cyclodienes aldrin, dieldrin, and endrin;
and the γ-isomer of hexachlorocyclohexane (lindane).
Chemical analysis procedure has been previously
reported [23,35]. Briefly, quantitative analyses of the OCPs
were undertaken on a gas-chromatography (GC)-electron
capture detector (63Ni) (HP6890 with HP2397A μECD,
Agilent Technologies Inc., CA, USA). A 5% phenyl methyl
siloxane capillary column of 30 m x 0.22 mm i.d. x 0.25 μm
(HP5 Supelco Co., Sigma-Aldrich Co., PA, USA) was used
throughout the analyses. The GC operating conditions were
as follows: carrier gas helium and argon-methane (95+5)
as make-up gas at a flow rate of 1.5 ml/minute; pulsed split-
less injection; an initial temperature of 50°C was held for 2
minutes, then the temperature was increased to 200°C at a
rate of 30°C/minute, and finally to 280°C at a rate of
5°C/minute. The analytical limit of detection was
1 ppb (ng/g fat) for all the analytes. The accuracy of
the analytical procedure was checked by using refer-
ence solutions of pure analytical grade.
The concentration of serum OCPs obtained in the chro-
matographic analysis was lipid-adjusted because lipid-
adjusted serum concentrations of lipophilic compounds
give a better estimation of the burden [38]. Total
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matic Hitachi Analyzer 717 (Boehringer Manheim, IN,
USA). Estimation of total serum lipids were calculated as
previously reported [39,40]:
TL (total lipids) = 2.27 TC (total cholesterol) +TG
(triglycerides) + 62.3
Due to the fact that o,p’-DDT, o,p’-DDE, and o,p’-DDD
were detected in a small percentage of samples, they were
not considered throughout this work. Thus, in this study
we refer to p,p’- isomers of DDT, DDE and DDD as DDT,
DDE and DDD, respectively. Similarly, we express the total
DDT body burden as the sum of the three OCP-DDTs iso-
mers more frequently measured (p,p´-DDT, p,p´-DDE, and
p,p´-DDD); the total cyclodienes body burden (total
Cyclodienes) as the sum of the three cyclodienes pesticides
measured (aldrin, dieldrin and endrin); and the total OCPs
body burden as the sum of the most frequently detected
OCPs and metabolites measured (p,p’-DDT, p,p’-DDE, p,p’-
DDD, aldrin, dieldrin, endrin, and lindane).
Statistical analysis
In our sample, the distribution of OCPs deviates signifi-
cantly from normality. For this reason, non-parametric tests
were employed. Thus, Mann–Whitney U-test was used to
explore differences in OCPs levels between groups. Chi
square test was used to compare differences in categorical
variables. Correlation between OCP levels and continuous
variables was analyzed with the Spearman’s correlation test.
In order to explore the possibility that other factors could
be determinants to OCPs serum levels, multivariate analysis
(binary logistic regression) test was used, adjusting for the
well-known confounding variables, such as age, body mass
index (BMI), menopausal status, lactation and smoking
habits. All test were two sided and considered as significant
if P< 0.05.
Results
The studied population included 103 healthy women
and 121 women diagnosed of BC, all of them from Gran
Canaria Island. Healthy women were younger than BC
patients (p< 0.001). Additionally, BMI values were
higher in BC patients than in healthy women (p= 0.031).
Related to menopausal status, most women from both
groups were premenopausal women (74.8 and 81% in
healthy and affected women, respectively). We observed
statistical differences regarding to the distribution of
menopausal status in the population (p= 0.024). We did
not observe statistical differences between groups
regarding to other demographical variables (Table 1).
A clear correlation between age and OCPs serum
levels was evident in the group of healthy women. Thus,
a positive relation between age and p,p´-DDE serum
values was evident (r= 0.320; p= 0.001), while serum
values of aldrin (r=−0.345; p< 0.001) and lindane(r=−0.242; p= 0.014) were negatively related to age. On
the contrary, we did not observe these associations in
the group of women affected of BC.
All analyzed samples had detectable residues of any
OCP; samples from BC patients had a higher number of
residues (an average of 3.66 different OCP residues per
sample; range: 1–6; median: 4) than samples from
healthy women (mean 3.25 OCPs per sample; range 2–7;
median 3) (p= 0.008).
As shown in Table 2, DDE (the main DDT-metabolite)
was detected in most samples from healthy women and
BC patients (89 and 97%, respectively). The other DDT-
metabolite, DDD, was also found in a high number of
serum samples (72%) from women suffering BC, but it
was detected in a small number of healthy subjects (6%)
(p< 0.001). Interestingly, the main component of tech-
nical DDT (p,p´-DDT), used in commercial formulations
of DDT and banned in Spain in last 1970’s, was present
in more than 70% of the samples from both groups of
women. With respect to non-DDT-derivatives, we
observed discrepant results. Thus, despite the fact that
the presence of residues of lindane and dieldrin was
similar in both groups of women (more than 20% in
both cases), the percentage of samples showing detect-
able levels of aldrin was clearly higher in BC patients
than in healthy women (74 vs. 38%; p< 0.001). On the
contrary, samples from healthy women showed a
high presence of residues of endrin compared with
samples from affected women (58 vs. 0%, respect-
ively) (Table 2). Interestingly, these differences were
observed also in the subgroup of subjects older than
45 years old (Table 3). The relative prevalence of
OCPs in both groups of women is summarized in
Figure 2.
As shown in Table 2 median value of DDT was higher
among healthy women than in affected women (217 vs.
153 ng/g lipid, respectively; p< 0.001). However, regard-
ing to DDE and DDD the residue levels were higher
among BC patients (p< 0.001 for both cases). As a con-
sequence, serum samples from affected women showed
higher median values of total DDT body burden (around
980 ng/g fat) than those values found in healthy women
(665 ng/g fat) (p= 0.001). On the contrary, total cyclo-
dienes body burden was higher in healthy women than
in serum samples from BC patients (p= 0.027).
Nevertheless, if we consider the total OCPs residues as
the sum of the three DDT-derivatives measured and the
sum of the three cyclodienes measured plus lindane, we
could observe that median levels of total OCP com-
pounds were higher in BC subjects than in healthy
women (p= 0.001) (Table 2). Moreover, this difference
was also observed in the subgroup of healthy women
and BC patients older than 45 years old (p= 0.043)
(Table 3).
Table 2 Levels of organochloride residues (ng/g lipid) detected in serum samples in healthy women and in women
diagnosed from breast cancer
Healthy women (n =103) Breast cancer women (n =121)
Mean± SD Median (p5-p95) D (%) Mean± SD Median (p5-p95) D (%) P
Lindane 24.7 ± 43.0 0.0(0.0-111.4) 28 (27.2%) 53.2 ± 88.8 0.0(0.0-220.0) 33 (27.3%) n.s.an.s.b
Aldrin 27.1 ± 37.9 0.0(0.0-100.1) 39 (37.9%) 72.5 ± 107.2 75.8(0.0-116.4) 90 (74.4%) <0.001a<0.001b
Dieldrin 9.5 ± 16.4 0.0(0.0-46.2) 33 (32.0%) 12.6 ± 29.5 0.0(0.0-72.0) 27 (22.3%) n.s.an.s.b
Endrin 231.4 ± 444.4 29.1(0.0-1279.0) 60 (58.3%) - - 0 (0%) n.a.an.a.b
TotalCyclodienes 268.1 ± 443.3 91.4(0.0-1297.8) 81 (78.6%) 85.2 ± 117.7 79.9(0.0-156.1) 95 (78.5%) n.sa0.027b
p,p-DDE 198.0 ± 207.5 167.7(45.0-706.0) 92(89.3%) 357.4 ± 326.0 300.1(106.1-653.3) 118 (97.5%) 0.012a<0.001b
p,p-DDD 21.8 ± 131.2 0.0(0.0-129.2) 6 (5.8%) 440.3 ± 412.7 551.1(0.0-1108.2) 87 (71.9%) <0.001a<0.001b
p,p-DDT 319.5 ± 417.4 217.0(0.0-1428.6) 77 (74.8%) 149.3 ± 111.7 153.0(0.0-327.9) 88 (72.7%) n.s.a<0.001b
Total DDTs 880.8 ± 971.9 665.0(69.1-3622.0) 103 (100%) 1049.6 ± 679.5 979.3(159.2-2228.7) 121 (100%) n.s.a0.001b
Total OCPs 1173.6 ±1339.9 706.0(242.7-5263.6) 103 (100%) 1188.1 ± 657.2 1112.8(184.2-2375.9) 121 (100%) n.s.a0.001b
Abbreviations: SD, standard deviation; D, detected compound; p5-p95, percentiles 5 and 95 of the distribution; n.s., non-significant; n.a., not applicable.
a χ2 test.
b Mann–Whitney U-test.
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(24.8%) presented a combination of aldrin, DDE, and
DDD, followed by DDD alone and DDD and DDE (10
subjects). Interestingly, we did not observe overlaps be-
tween these OCP-mixtures among both groups of
women, that is: no healthy subject had combination of
residues of aldrin plus DDE plus DDD, and no BC pa-
tient had combination of residues of lindane plus endrin.
Finally, since age, BMI and menopausal status seem to
play an important role in BC etiology [41], and having
into account that these parameters and others (such as
lactation, and smoking habits) seem to be important
determinants of the levels of contamination by OCPs
[23,35,42], we carried out a multivariate analysis, includ-
ing all the pesticides simultaneously in the model and
adjusting by age, BMI, menopause status, lactation andTable 3 Levels of organochloride residues (ng/g lipid) detecte
diagnosed from breast cancer older than 45 years old
Healthy women (n= 49)
Mean± SD Median (p5-p95) D (%)
Lindane 16.6 ± 34.6 0.0(0.0-104.5) 10 (20.4%)
Aldrin 15.0 ± 27.5 0.0(0.0-73.2) 12 (24.5%)
Dieldrin 7.0 ± 16.0 0.0(0.0-49.7) 10 (20.4%)
Endrin 234.2 ± 466.0 0.0(0.0-1553.1) 24 (49.0%)
TotalCyclodienes 256.1 ± 463.6 46.5(0.0-1553.1) 33 (67.3%)
p,p-DDE 275.6 ± 266.2 220.8.7(0.0-653.1) 46 (93.9%)
p,p-DDD 8.6 ± 38.3 0.0(0.0-94.3) 3 (6.1%)
p,p-DDT 324.8 ± 395.5 205.4(0.0-1334.6) 40 (81.6%)
Total DDTs 937.3 ± 824.2 706.0(133.2-3017.4) 49 (100%) 1
Total OCPs 1210.1 ± 1243.6 729.7(267.9-4570.5) 49 (100%) 1
Abbreviations: SD, standard deviation; D, detected compound; p5-p95, percentiles 5
a χ2 test.
b Mann–Whitney U-test.smoking habits; in order to evaluate the existence of any
association between OCPs´ exposure and a BC risk. As
shown in Table 4, among the OCPs evaluated, only p,p’-
DDD showed a moderate increment in the risk of devel-
oping BC (odds ratio 1.008 [95%CI, 1.001-1.015],
p = 0.024).
Discussion
Although the vast majority of epidemiologic studies do
not support the association between BC and OCPs
[15,20,32,43,44], the well-known association between BC
and prolonged exposure to estrogens suggests that envir-
onmental estrogens, may play a critical role in the cellu-
lar and molecular changes that occur during breast
carcinogenesis [45]. In this sense, most OCPs are con-
sidered as xenoestrogens and may modulate steroid sexd in serum samples in healthy women and in women
Breast cancer women (n =105)
Mean± SD Median (p5-p95) D (%) P
49.5 ± 85.4 0.0(0.0-215.2) 27 (25.7%) n.s.an.s.b
71.7 ± 114.3 74.8(0.0-115.7) 76 (72.4%) <0.001 a<0.001 b
12.2 ± 30.0 0.0(0.0-71.7) 22 (21.0%) n.s.an.s.b
- - 0 (0%) n.a.an.a.b
83.9 ± 125.2 77.5(0.0-156.7) 80 (76.2%) n.s.an.s.b
354.5 ± 327.3 303.8(106.1-648.8) 102 (97.1%) n.s.a0.003b
412.4 ± 412.1 126.5.1(0.0-1094.7) 72 (68.6%) <0.001a<0.001b
153.2 ± 114.0 158.7(0.0-327.3) 76 (72.4%) n.s.a0.008b
022.7 ± 684.7 892.7(143.0-2225.8) 105 (100%) n.s.an.s.b
156.0 ± 661.1 1057.3(181.7-2364.8) 105 (100%) n.s.a0.043b
and 95 of the distribution; n.s., non-significant; n.a., not applicable.
Figure 2 Frequency of detection of organochlorine pesticides among breast cancer patients and healthy women.
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as agonists or antagonists or as mixed effects [46]. In
fact, there are a number of studies that seem to indicate
that the association between BC and OCPs could exist
[27,47].
The best known and studied OCP with respect to its
role in breast cancer is the main DDT-metabolite, DDE.
DDT is converted to DDE, that apparently does not
undergo further biotransformation, and it is stored for
an indefinite period of time in adipose tissues. Due to
this fact, this compound is the highest prevalent DDT-
derivative found in human beings [18]. On the other
hand, the major detoxification pathway of DDT is via
dechlorination to DDD. The population of the Canary
Islands presents similar serum levels of DDT and DDE
to those found in other European countries [23]. In the
present study, serum levels of DDE were higher in BC
patients than in healthy women, although, after a multi-
variate analysis, DDE do not seem to be a risk factor forTable 4 Binary logistic regression of pesticide in
multivariate analysis adjusted by age, BMI, menopausal
status, lactation and smoking habits
Pesticide Odds ratio, 95% CI P
Healthy women (Ref. category)
Lindane 1.097 (0.420-28.412) 0.988
Aldrin 1.027 (0.991-1.065) 0.147
Dieldrin 1.002 (0.956-1.050) 0.927
Endrin N.A.
p,p’-DDD 1.008 (1.001-1.015) 0.024
p,p’-DDE 0.999 (0.996-1.001) 0.284
p,p’-DDT 0.994 (0.987-1.002) 0.139
Abbreviations: 95% CI, 95% confidence interval; N.A., not applicable.BC. These results agree with those reported previously
[32]. However, there are other highly prevalent OCPs
(DDT- and non-DDT-derivatives) in female populations
at concentrations highly enough to exert biological
effects on breast cells [34]. In this sense, our findings
demonstrating that serum levels of DDD were higher
among BC patients than in non-affected women and
that exposure to DDD could represent, at least, a moder-
ately risk factor for developing BC (OR= 1.008), point to
the possibility that other less evaluated OCPs, such as
DDD, could play a more relevant role as risk factor for
BC.
We reported that background exposure to non-DDT-
derivative-OCPs was higher in non-affected women than
in BC patients. This result was mainly due to the fact
that endrin was not detected in any sample from BC
patients, while residues of endrin were present in more
than 58% of the samples from healthy women at median
concentrations higher than 29 ng/g fat. On the contrary,
the presence of residues of aldrin was higher in serum
samples from BC patients than in healthy women. Thus,
depending on the specific subclass of OCP, the environ-
mental exposure to these contaminants might be related
or not with the etiology of BC. Our results showing that
DDD could be considered as risk factors for BC must be
taken with caution due to the several limitations of our
study. Firstly, controls were originally selected for a dif-
ferent purpose (ENCA survey) than analyzed in this
study. The use of controls from a nutritional survey may
introduce bias if the probability of selection into the
study is associated with factors that influence both the
prevalence of exposure and the probability of disease
status. One such factor is age, which was statistically dif-
ferent among groups of subjects (47.6% of healthy
women were older than 45 years old while 86.8% of BC
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or menopause status (both variables also considered as
BC risk factors and important for the prevalence of ex-
posure to OCPs). Secondly, several established risk fac-
tors for breast cancer (mainly family history of breast
cancer, reproductive factors (such as number of children
or duration of lactation), or alcohol intake) were not
available nor in controls nor in BC patients, and, as a
consequence, unmeasured or residual confounding fac-
tors have not been included in the analyses. Thirdly, be-
cause these chemicals are stored in fat, it is believed that
adipose tissue loss could result in increased \organ and
blood concentrations of these compounds [48]. Thus, if
changes in body weight occur as a consequence of the
development of cancers, the levels of OCPs measured in
this study may not reflect the background exposure to
these chemicals for both groups of women. In addition,
body fat is an important risk factor for breast cancer
[49]. Although we adjusted for BMI in our analyses,
BMI as a measure of body fat has certain limitations
[50]. To make matters worse, because serum concentra-
tions of OCPs are highly correlated with each other and
can be correlated with unmeasured substances, the asso-
ciations observed here might not always have repre-
sented the direct effect of the OCPs measured.
It is assumed that the biological effects exerted by en-
vironmental contaminants on human tissues, taken indi-
vidually, clearly differ from the effects exerted by their
combinations. However, most studies about environ-
mental contaminants as risk factors for BC have focused
on single-chemicals. Currently, it seems clear the im-
portance of the exposure to chemical mixtures and their
contribution to the disease by causing cellular-level dys-
function along key pathways. In this sense, we have re-
cently reported that DDD, DDE, aldrin, and dieldrin,
sharply upregulated the expression of a number of pro-
tein kinases genes that could be involved in the etiology
of BC, such as ACVRL1, ALK-1, KIT, ERBB3, and ALK-
1, at concentrations close to those detected in human
populations [34]. Additionally, it has to be taken into ac-
count that the potential effects exerted on breast cells by
environmental contaminants could be due not only to
the organochlorine pesticides measured in the present
study, even more so other environmental pollutants not
measured could be implicated. Complex interactions be-
tween chemicals, endogenous or exogenous hormones,
and their natural ligands and receptors may alter the in-
ternal homeostasis of the estrogenic environment of
mammary tissue, leading to malignant transformation
and cancer. Our findings agree with those observed
in vitro by Aubé (2011) suggesting that aldrin and DDD,
together with other OCP compounds, increased the pro-
liferation of MCF-7 cells [51]. However, to our know-
ledge, population-based studies evaluating the role ofOCPs mixtures in relation to breast cancer are scarce
[52]. Our findings showing the lack of overlaps between
the profiles of mixtures of OCPs among healthy and
affected women suggest a relevant role of these chemical
mixtures in relation to the disease. Future studies
achieving the association between environmental con-
taminants and BC should analyze the combined effect of
these compounds and the interactions with endogenous
hormones and other substances that affect endocrine
function.
Conclusions
In conclusion, our results indicate that serum concentra-
tions of OCPs were higher in BC patients than in
healthy women in this specific sample of the Spanish
population, and suggest that the combination of certain
OCPs could be highly relevant in the potential role
played by these chemicals as risk factors for BC. More
specifically, our results seem to indicate that the mixture
of aldrin plus DDE plus DDD, may play a relevant role
of as a potential environmental factor related to BC. In
this context, despite the controversial and complex
issues involved with continued exposure to residues of
OCPs through the environment and food, their potential
role as risk factor for BC, should be considered by Public
Health Authorities in countries where BC alarming rates
of BC incidence or mortality exists.
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